MedMira Inc.: Diferență între versiuni
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
MedMira Inc. (http://medmira.com/) is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four [[test]] results using [[one]] test cartridge and one drop of specimen. It also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The Company sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others. | MedMira Inc. (http://medmira.com/) is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four [[test]] results using [[one]] test cartridge and [[ONE|one]] drop of specimen. It also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The Company sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== |
Versiunea curentă din 17 noiembrie 2024 09:04
Pagina dedicata companiei MedMira Inc. listata cu simbolul CA.MIR
Descriere companie[edit | ]
MedMira Inc. (http://medmira.com/) is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. It also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The Company sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.
Grafic actiuni companie[edit | ]